Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2003
10/15/2003CN1124139C Chinese medicine powder for treating rheumatoid arthritis
10/15/2003CN1124138C Male silkmoth capsule and its preparing process
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632651 Tissue maintenance system that applies rhythmic pulses of pressure
10/14/2003US6632648 Methods of terminal sterilization of fibrinogen
10/14/2003US6632647 Use of strains of parapoxvirus ovis against organ fibrosis
10/14/2003US6632628 Use to detect compounds having therapeutic activity toward cardiac hypertrophy
10/14/2003US6632608 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/14/2003US6632446 Biocompatible substrates; free radical polymerization initiator; crosslinked networks of water soluble polymers; acrylated polyethylene glycol; microencapsulation
10/14/2003US6632443 Water-soluble compositions of bioactive lipophilic compounds
10/14/2003US6632440 Chronic obstructive pulmonary disease (COPD), asthma; Aerosol administration a compound that inhibits exocytosis in mucus secreting cells produced by modifying a clostridial neurotoxin
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003CA2041394C Osteogenic composition and implant containing same
10/10/2003CA2423738A1 Method of producing a preparation containing active substances from cannabis
10/09/2003WO2003083092A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003WO2003083091A1 Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof
10/09/2003WO2003083089A2 Tolerogenic antigen-presenting cells
10/09/2003WO2003083088A2 Stem cell therapy
10/09/2003WO2003083080A2 Mixed- cell gene therapy
10/09/2003WO2003083069A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003WO2003083065A2 Improved methods for achieving expression from alphavirus vectors
10/09/2003WO2003083064A2 Chimeric pancreas
10/09/2003WO2003082990A1 A natural fluorescent dye obtained from a marine invertebrate, compositions containing the said dye and their uses
10/09/2003WO2003082989A1 A natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses
10/09/2003WO2003082348A1 Nanogel networks including polyion polymer fragments and biological agent compositions thereof
10/09/2003WO2003082345A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
10/09/2003WO2003082328A1 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway
10/09/2003WO2003082323A1 A composition and method for killing of tumours
10/09/2003WO2003082307A1 Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
10/09/2003WO2003082306A1 Lactobacillus iners for the enhancement of urogenital health
10/09/2003WO2003082305A1 Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
10/09/2003WO2003082302A2 Bioadhesive directed somatic cell therapy
10/09/2003WO2003082269A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003WO2003082201A2 Collagen biofabric and methods of preparation and use therefor
10/09/2003WO2003082200A2 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003WO2003082027A1 Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
10/09/2003WO2003059376A8 The use of il6r/il6 chimera in nerve cell regeneration
10/09/2003WO2003055990A3 Method for culturing and expansion of mammalian undifferentiated epidermal keratinocytes exhibiting stem cell characteristics
10/09/2003WO2003049667A3 The method of treating cancer
10/09/2003WO2003045405A3 Lactic acid bacteria and their use for treating and preventing cancer
10/09/2003WO2003041634A3 Bag system for cryopreservation of body fluids
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003034981A3 Prevention of recurrent viral disease
10/09/2003WO2003032923A3 Induction of beta cell differentiation in human cells
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003020904A3 Methods of generating human cd4+ th1 cells
10/09/2003WO2003020116A3 Fixed-dried red blood cells
10/09/2003WO2002102828A3 Chimeric flavivirus vectors
10/09/2003WO2002076386A3 Method of inducing proliferation of retinal stem cells
10/09/2003WO2002059315A3 Human nucleic acids and polypeptides and methods of use thereof
10/09/2003WO2002057429A3 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype
10/09/2003WO2002056905A3 Molecular antigen array
10/09/2003WO2002030433A3 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia
10/09/2003WO2002022664A3 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
10/09/2003WO2002016612A3 Genes and proteins, and their uses
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2001085917A3 A device
10/09/2003US20030191080 Cardiovascular disorders; hypotensive agents
10/09/2003US20030190740 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment
10/09/2003US20030190732 Plasma fraction containing bikunin, method for the production thereof and use of the same
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190330 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003US20030190324 Immunologically significant herpes simplex virus antigens and methods for using same
10/09/2003US20030190315 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines
10/09/2003US20030190314 Administering spray dried plasma for modulating immunoglobulin levels; vaccines; for weight gain; autoimmune disorders
10/09/2003US20030190309 Novel probiotics for pet food applications
10/09/2003US20030190306 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/09/2003CA2519642A1 A composition and method for killing of tumours
10/09/2003CA2480751A1 Tolerogenic antigen-presenting cells
10/09/2003CA2480656A1 Bioadhesive directed somatic cell therapy
10/09/2003CA2480634A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003CA2480387A1 Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
10/09/2003CA2480324A1 A natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses
10/09/2003CA2480263A1 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003CA2479903A1 Collagen biofabric and methods of preparation and use therefor
10/09/2003CA2479763A1 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003CA2479110A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/08/2003EP1350608A2 Guard and control apparatuses for sliding compound mitre saw
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1349919A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349869A1 Method of identifying antibacterial compounds
10/08/2003EP1349837A1 Antitumoral carbazoles
10/08/2003EP1349613A2 Thrombopoietin mimetics
10/08/2003EP1349570A1 ENTEROHEMORRAGIC i ESCHERICHIA COLI /i VACCINE
10/08/2003EP1349563A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders
10/08/2003EP1349557A2 Fractions of snake blood, their preparation and use as therapeutic agents
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP0920523B1 Hsv strain lacking functional icp27 and icp34.5 genes
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0819010B1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous sucrose solution
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447920A Compsns. and methods for modulating tumor specific expression
10/08/2003CN1447850A Purifying crude pufa oils
10/08/2003CN1446546A Biology calcium health foods made from sierra fish bone and its preparation method
10/08/2003CN1123358C Oral liquid for treating cerebrovascular disease
10/08/2003CN1123357C Medicine for wholly conditioning viscera
1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 1259